SCHEMBL4616013

SCHEMBL4616013

Cc1cc(C)c(S(=O)(=O)c2ccc(F)cc2)cc1S(=O)(=O)Cl

nearest known ligand 0.43

Predicted protein targets (top 19)

geneUniProtsupporting neighboursconfidence
KMT2A Q03164 3/20 0.42
MEN1 O00255 2/20 0.42
FFAR4 Q5NUL3 1/20 0.41
HSD11B1 P28845 1/20 0.41
MAPT P10636 1/20 0.39
TSHR P16473 1/20 0.39
RXFP1 Q9HBX9 1/20 0.38
COMT P21964 1/20 0.37
PTGS2 P35354 1/20 0.37
HTR2A P28223 2/20 0.37
HTR2C P28335 2/20 0.37
KCNH2 Q12809 2/20 0.37
LMNA P02545 2/20 0.37
PKM P14618 1/20 0.37
RXRA P19793 1/20 0.37
RXRB P28702 1/20 0.37
RXRG P48443 1/20 0.37
HTT P42858 1/20 0.36
SMN1; SMN2 Q16637 1/20 0.36

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL4616004 0.83 LMNA (0.45) KMT2AMEN1FFAR4HSD11B1MAPT
SCHEMBL4616550 0.83 ALDH1A1 (0.47) KMT2AMEN1MAPTPKMHTT
SCHEMBL31356933 0.79 NAMPT (0.47) KMT2AMEN1FFAR4HSD11B1MAPT
SCHEMBL27733509 0.79 MEN1 (0.50) KMT2AMEN1FFAR4HSD11B1RXFP1
SCHEMBL10788369 0.78 HSD11B1 (0.45) KMT2AMEN1FFAR4HSD11B1MAPT
SCHEMBL9339232 0.78 RAPGEF4 (0.41) KMT2AMEN1MAPTTSHRLMNA
SCHEMBL8978705 0.77 HSD11B1 (0.47) KMT2AMEN1FFAR4HSD11B1MAPT
SCHEMBL9398076 0.77 ALDH1A1 (0.58) KMT2AMEN1FFAR4LMNASMN1; SMN2
SCHEMBL4617330 0.76 HTR2A (0.43) KMT2AMEN1HSD11B1MAPTCOMT
SCHEMBL4618067 0.76 MEN1 (0.54) KMT2AMEN1FFAR4HSD11B1RXFP1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-101208299-A Diarylsulfone sulfonamides and use therof WYETH CORP (US) 2008-06-25 CN disclosed
EP-1879859-A2 DIARYLSULFONE SULFONAMIDES AND USE THEROF Wyeth a Corporation of the State of Delaware (US) 2008-01-23 EP disclosed
US-20060276464-A1 Diarylsulfone sulfonamides and use thereof WYETH (US) 2006-12-07 US disclosed
WO-2006124875-A2 DIARYLSULFONE SULFONAMIDES AND USE THEROF WYETH (US) 2006-11-23 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20060276464-A1 Diarylsulfone sulfonamides and use thereof SFRP1, SOS1, FZD7 KMT2A 3832/4885MEN1 886/4885FFAR4 1926/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.